This menu provides the list of EV mRNAs identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Maximum false positive rate (FPR): Maximum true positive rate (TPR):
  - FPR is the probability that an absent mRNA accidently have higher intensity than that mRNA.
  - TPR is the percentile of mRNA among the present mRNAs.
    Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Since there are multiple primers in the microarray, the same mRNA can have several FPR and TPR values.

mRNA name UniProt accession FPR TPR Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 9.0e-10 3.7e-1Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.
Nat Cell Biol. 2008 Dec;10(12):1470-6. doi: 10.1038/ncb1800. Epub 2008 Nov 16.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 4.2e-11 3.4e-1Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.
Nat Cell Biol. 2008 Dec;10(12):1470-6. doi: 10.1038/ncb1800. Epub 2008 Nov 16.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 1.7e-5 4.8e-1Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.
Nat Cell Biol. 2008 Dec;10(12):1470-6. doi: 10.1038/ncb1800. Epub 2008 Nov 16.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 1.9e-7Mesenchymal stem cell-derived microvesicles protect against acute tubular injury.
J Am Soc Nephrol. 2009 May;20(5):1053-67. doi: 10.1681/ASN.2008070798. Epub 2009 Apr 23.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 3.3e-1Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats.
J Cell Mol Med. 2010 Jun;14(6B):1605-18. doi: 10.1111/j.1582-4934.2009.00860.x. Epub 2009 Jul 24.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 3.9e-1Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats.
J Cell Mol Med. 2010 Jun;14(6B):1605-18. doi: 10.1111/j.1582-4934.2009.00860.x. Epub 2009 Jul 24.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 4.2e-3Nanostructural and transcriptomic analyses of human saliva derived exosomes.
PLoS One. 2010 Jan 5;5(1):e8577. doi: 10.1371/journal.pone.0008577.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 3.5e-1Nanostructural and transcriptomic analyses of human saliva derived exosomes.
PLoS One. 2010 Jan 5;5(1):e8577. doi: 10.1371/journal.pone.0008577.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 1.7e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 1.8e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 1.7e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 1.7e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 1.7e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 1.7e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 1.7e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 1.7e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 1.9e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 1.9e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 3.5e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 3.4e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 3.3e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 3.3e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 3.2e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 3.2e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 3.3e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 3.4e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 3.6e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 3.6e-1RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 2.3e-1Identifying mRNA, microRNA and protein profiles of melanoma exosomes.
PLoS One. 2012;7(10):e46874. doi: 10.1371/journal.pone.0046874. Epub 2012 Oct 9.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 2.6e-1Identifying mRNA, microRNA and protein profiles of melanoma exosomes.
PLoS One. 2012;7(10):e46874. doi: 10.1371/journal.pone.0046874. Epub 2012 Oct 9.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 1.5e-1Identifying mRNA, microRNA and protein profiles of melanoma exosomes.
PLoS One. 2012;7(10):e46874. doi: 10.1371/journal.pone.0046874. Epub 2012 Oct 9.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 2.7e-1Identifying mRNA, microRNA and protein profiles of melanoma exosomes.
PLoS One. 2012;7(10):e46874. doi: 10.1371/journal.pone.0046874. Epub 2012 Oct 9.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 4.4e-1First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.
Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 1.9e-1Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 2.4e-13 2.9e-1Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 0.0e+0Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing.
RNA Biol. 2016 Oct 28:0.
ENOG410YTDG15 / 0 / 15
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769 0.0e+0 3.3e-1The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma.
J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016.
ENOG410YTDG15 / 0 / 15
[1]